After 14 days of treatment, 64.6% of the patients taking ... More information: Jun Hamano et al, Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind ...

Background: Methylnaltrexone has been shown to be effective for treating opioid-induced constipation (OIC ... the use of methylnaltrexone for the treatment of OIC in patients with chronic ...

Rizmoic is a once-daily 200-microgram oral tablet for the treatment of opioid induced constipation (OIC) in adult patients previously treated with a laxative. Shionogi received EU marketing ...

Dulcolax and Colace can also be used for opioid-induced constipation (OIC ... what OTC options are best for your specific ...

Stomachaches and pains can occur for various reasons, including constipation, gas, and heartburn. In some cases, ...

a mu-opioid receptor antagonist for the treatment of opioid induced constipation; Nouriast/ Nourianz, an adenosine receptor antagonist for Parkinson’s disease; and ORKEDIA, an oral calcimimetics ...

Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study Preventive use of naldemedine for ...

This pilot study suggests that methylnaltrexone actively induces laxation and is generally well tolerated in patients receiving mu-opioid analgesia, following orthopedic surgery, who develop OIC ...

a mu-opioid receptor antagonist for the treatment of opioid induced constipation; Nouriast/ Nourianz, an adenosine receptor antagonist for Parkinson’s disease; and ORKEDIA, an oral calcimimetics ...